es cell clones (Zymo Research)
Zymo Research is a verified supplier 
Zymo Research manufactures this product 
95
Structured Review
Zymo Research
es cell clones
Es Cell Clones, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es+cell+clones/Quick-DNA+96+Plus+Kit/pm40403729-1036-7-13
Average 95 stars, based on 152 article reviews
Es Cell Clones, supplied by Zymo Research, used in various techniques. Bioz Stars score: 95/100, based on 152 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/es+cell+clones/Quick-DNA+96+Plus+Kit/pm40403729-1036-7-13
Average 95 stars, based on 152 article reviews
es cell clones - by Bioz Stars,
2026-11
95/100 stars
Images
Related Articles
Plasmid Preparation:Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types Article Snippet: .. The targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100-150 μg/ml for 5 days, monoclonal populations of cells were hand-picked and expanded. gDNA was prepared from the modified Control:Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types Article Snippet: .. The targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100-150 μg/ml for 5 days, monoclonal populations of cells were hand-picked and expanded. gDNA was prepared from the modified Selection:Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types Article Snippet: .. The targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100-150 μg/ml for 5 days, monoclonal populations of cells were hand-picked and expanded. gDNA was prepared from the modified Modification:Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types Article Snippet: .. The targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100-150 μg/ml for 5 days, monoclonal populations of cells were hand-picked and expanded. gDNA was prepared from the modified Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types. Article Snippet: Each targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100–150 μg/mL for 5 days, monoclonal populations of cells were hand-picked and expanded. .. Genomic DNA was prepared from the modified Clone Assay:Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types Article Snippet: .. The targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100-150 μg/ml for 5 days, monoclonal populations of cells were hand-picked and expanded. gDNA was prepared from the modified Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types. Article Snippet: Each targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100–150 μg/mL for 5 days, monoclonal populations of cells were hand-picked and expanded. .. Genomic DNA was prepared from the modified Real-time Polymerase Chain Reaction:Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types Article Snippet: .. The targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100-150 μg/ml for 5 days, monoclonal populations of cells were hand-picked and expanded. gDNA was prepared from the modified Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types. Article Snippet: Each targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100–150 μg/mL for 5 days, monoclonal populations of cells were hand-picked and expanded. .. Genomic DNA was prepared from the modified Polymerase Chain Reaction:Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types Article Snippet: .. The targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100-150 μg/ml for 5 days, monoclonal populations of cells were hand-picked and expanded. gDNA was prepared from the modified Article Title: A suite of enhancer AAVs and transgenic mouse lines for genetic access to cortical cell types. Article Snippet: Each targeting vector (30 μg of DNA) was then co-electroporated with a plasmid containing a mouse codon optimized Bxb1 gene under the control of the cytomegalovirus (CMV) promoter (100 μg of DNA) into the Bxb1-landing pad ES cell line and following hygromycin drug selection at 100–150 μg/mL for 5 days, monoclonal populations of cells were hand-picked and expanded. .. Genomic DNA was prepared from the modified |